Filing Details
- Accession Number:
- 0001225208-22-006816
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-10 20:54:42
- Reporting Period:
- 2022-05-07
- Accepted Time:
- 2022-05-10 20:54:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196661 | Jr E Donald Bobo | One Edwards Way Irvine CA 92614 | Cvp,Strategy/Corp Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-07 | 604 | $100.52 | 59,316 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-05-08 | 12,600 | $0.00 | 71,916 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-05-08 | 7,612 | $100.52 | 64,304 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2022-05-09 | 6,725 | $35.20 | 71,029 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-05-09 | 6,725 | $98.71 | 64,304 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Rights | Disposition | 2022-05-08 | 12,600 | $0.00 | 12,600 | $0.00 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2022-05-09 | 6,725 | $0.00 | 6,725 | $35.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-05-08 | 2026-05-07 | No | 4 | M | Direct |
| 73,975 | 2017-05-12 | 2023-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 38,268 | Indirect | 401(k) |
| Common Stock | 117,320 | Indirect | By Trust |
Footnotes
- On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.
Billionaire Hedge Funds
